Estradiol (E) mitigates acute and postacute adverse effects of 12 hr-food deprivation (FD) on energy balance. Hindbrain 5 0 -monophosphate-activated protein kinase (AMPK) regulates hyperphagic and hypothalamic metabolic neuropeptide and norepinephrine responses to FD in an E-dependent manner. Energy-state information from AMPK-expressing hindbrain A2 noradrenergic neurons shapes neural responses to metabolic imbalance. Here we investigate the hypothesis that FD causes divergent changes in A2 AMPK activity in E-vs. oil (O)-implanted ovariectomized female rats, alongside dissimilar adjustments in circulating metabolic fuel (glucose, free fatty acids [FFA]) and energy deficit-sensitive hormone (corticosterone, glucagon, leptin) levels. FD decreased blood glucose in oil (O)-but not E-implanted ovariectomized female rats and elevated and reduced glucagon levels in O and E, respectively. FD decreased circulating leptin in O and E, but increased corticosterone and FFA concentrations in E only. Western blot analysis of laser-microdissected A2 neurons showed that glucocorticoid receptor type II and very-long-chain acyl-CoA synthetase 3 protein profiles were amplified in FD/E vs. FD/O. A2 total AMPK protein was elevated without change in activity in FD/O, whereas FD/E exhibited increased AMPK activation along with decreased upstream phosphatase expression. The catecholamine biosynthetic enzyme dopamine-b-hydroxylase (DbH) was increased in FD/O but not FD/E A2 cells. The data show discordance between A2 AMPK activation and glycemic responses to FD; sensor activity was refractory to glucose decrements in FD/O but augmented in FD/E despite stabilized glucose and elevated FFA levels. Edependent amplification of AMPK activity may reflect adaptive conversion to fatty acid oxidation and/or glucocorticoid stimulation. FD augmentation of A2 DbH protein profiles in FD/O but not FD/E animals suggests that FD may correspondingly regulate NE synthesis vs. metabolism/release in the absence vs. presence of E. Mechanisms underlying translation of E-contingent A2 neuron responses to FD into regulatory signaling remain to be determined. V C 2016 Wiley Periodicals, Inc.
The brain is integral for preservation of systemic energy homeostasis because of its ability to monitor and initiate compensatory responses to bodywide disturbances in nutrient and stored energy fuel availability. The enzyme 5 0 -monophosphate-activated protein kinase (AMPK) provides crucial input on brain cell ATP availability to neural pathways that safeguard systemic energy stability. This ultrasensitive, evolutionarily conserved energy gauge is activated via phosphorylation in response to metabolic stressors (exercise, starvation, hypoxia, etc.) that increase the intracellular AMP/ATP ratio (Hardie, 2003; Kahn et al., 2005) . Phosphorylated AMPK (pAMPK) inhibits ATP-consuming biosynthetic pathways while augmenting ATP-producing metabolic functions such as fatty acid oxidation. AMPK is expressed in hypothalamic and hindbrain elements of the sizable brain metabolic regulatory network. Hindbrain caudal dorsal vagal complex (cDVC) AMPK is implicated in neural regulation of feeding (Hayes et al., 2009; Alenazi et al., 2015) and glucostasis (Ibrahim et al., 2013) . DVC AMPK responds to substrate fuel availability; activation of this sensor by insulin-induced hypoglycemia is normalized by localized infusion of the oxidizable glucose metabolite Llactate (Gujar et al., 2014) .
Short-term abstinence from food intake, planned or unplanned, is unavoidable in modern life but is negatively correlated with appetite control and obesity. The ovarian hormone estradiol (E) limits acute refeeding after shortterm feeding suspension (12-hr food deprivation; FD), but augments acute refeeding when FD coincides with hindbrain energy depletion, mimicked by caudal fourth ventricular (CV4) administration of the AMPK activator 5-aminoimidazole-4-carboxamide-riboside (AICAR; . This compound's metabolic stress also exerts E-dependent effects during later resumption of circadian-induced food intake, e.g., increased consumption vs. weight gain in the presence vs. absence of E. These results signify that E mitigates acute and postacute adverse effects of disrupted fuel acquisition on systemic energy balance. cDVC AMPK impacts E influence; E-vs. oil (O)-implanted ovariectomized (OVX) female rats exposed to FD display divergent patterns of cDVC AMPK activation as well as disparate adjustments in feeding and hypothalamic AMPK phosphorylation, metabolic neurotransmitter expression, and norepinephrine activity after intra-CV4 delivery of the AMPK inhibitor compound C . Compound C treatment of FD/E but not FD/O animals normalizes food intake to full-fed ad libitum levels, implying that, in the presence of E, primary if not exclusive impetus to refeed emanates from this sensor. A2 noradrenergic neurons are a plausible source of E-dependent AMPK signaling during FD because this neurochemical phenotype is the sole cDVC cell population identified to date as AMPK positive and is, moreover, capable of integrating steroidal and metabolic stimuli by virtue of estrogen receptor-a (ERa) and -b (ERb) protein expression (Ibrahim et al., 2013) . Application of microlaser technology to optical systems provides an unparalleled means for selective procurement of pure nerve cell populations from native tissue for gene and/or protein expression analysis. Here, pure A2 nerve cell samples obtained by single-cell laser-catapult microdissection were analyzed for protein content by high-sensitivity Western blotting to address the premise that E regulates FD-induced patterns of A2 nerve cell AMPK and/or pAMPK expression in OVX female rats. Our prior work showed that hypoglycemic effects on A2 AMPK activity correlate with altered expression of the AMPK upstream kinase Ca 21 /calmodulin-dependent protein kinase-b (CAMKKb) and protein phosphatase PP2A (Tamrakar et al., 2015) . In light of evidence that cDVC AMPK activity is enhanced to a greater degree in FD/E than in FD/O female rats following CV4 AICAR administration , we speculate here that upstream kinase and/or phosphatase proteins may be reactive to FD in an E-conditional manner.
A further aim of this project was to investigate the impact of E on substrate fuel and endocrine signals of FD as well as A2 nerve cell receptivity to these FD surrogates. Available studies focus on male rats, in which FD of 4-10-hr duration reportedly decreases blood glucose while elevating free fatty acid (FFA; Le Magnon et al., 1980) . Here, we examined whether FD alters circulating metabolic fuel (glucose, FFA) and energy deficit-sensitive hormone (corticosterone, glucagon, ghrelin) levels in females and whether E is involved in those responses. We also addressed the hypothesis that A2 profiles of fatty acid (FA) metabolic proteins, e.g., acyl-coenzyme A synthetase long-chain FA activator (ACSVL-3; also referred to as FA transporter protein FATP3); SLC5A8, an Na 1 -coupled L-lactate and short-chain FA transporter (Martin et al., 2006) ; and the FA translocase FAT/CD36, which is implicated in FA sensing in the hypothalamus (Moull e et al., 2013 (Moull e et al., , 2014 , are modified differently in OVX 1 O vs. OVX 1 E. The type II glucocorticoid receptor (GR) transduces regulatory effects of normal and elevated corticosterone secretion on cell targets throughout the central neuroaxis. GR immunoreactivity (-ir) is localized to the nucleus of the solitary tract, the sensory component of the DVC (Ahima and Harlan, 1990; Cintra et al., 1994) , where GR-ir-positive neurons are transcriptionally activated in response to hypoglycemia (Kale et al., 2007) . The present study analyzes GR protein expression in A2 neurons by Western blot to verify that A2 cells express this receptor protein and to determine whether FD exerts differential effects on this protein in the presence vs. absence of E.
MATERIALS AND METHODS

Animals
Adult female Sprague Dawley rats (250-300 g bw) were maintained under a 14-hr light:10-hr dark schedule (lights on at 0500 hr) and allowed free access to standard laboratory rat chow (Harlan Teklad LM-485; Harlan Industries, Madison, WI) and water. Animals were accustomed to daily handling. All experimental protocols were conducted in accordance with NIH guidelines for the care and use of laboratory animals, with approval by the University of Louisiana at Monroe Institutional Animal Care and Use Committee.
Experimental Design
On day 1, rats were anesthetized with ketamine:xylazine (0.1 ml/100 g bw i.p., 90 mg ketamine:10 mg xylazine/ml; Henry Schein, Melville, NY), bilaterally ovariectomized, and implanted with a subcutaneous silastic capsule (0.062 in. i.d. 3 0.125 in. o.d.; 10 mm/100 g bw) loaded with 30 mg E/ml safflower oil or O alone (Briski et al., 2001 ). This steroid replacement regimen yields approximate plasma E concentrations of 22 pg/ml, replicating circulating hormone levels characteristic of metestrus in 4-day (Butcher et al., 1974) or diestrus day 2 in 5-day ovary-intact cycling animals (Goodman, 1978) . Animals were injected with ketoprofen (1 mg/kg bw s.c.) before and after surgeries; closed incisions were treated topically with 0.25% bupivacaine. At 2100 hr on day 7, E and O animals were randomly divided into full-fed (FF; n 5 3 FF/E, n 5 3 FF/O) and FD groups, at which time food was removed from n 5 3 FD/E and n 5 3 FD/O. On day 8, rats were sacrificed at 0900 hr for trunk blood and brain tissue collection. Brains were immediately snap-frozen in liquid nitrogen-cooled isopentane prior to storage at -80 8C. Trunk blood was collected for blood glucose and plasma hormone measurements. No animals were excluded from the study.
Western Blot Analysis of Laser-Catapult Microdissected Hindbrain DVC A2 Noradrenergic Neurons
Serial 10-lm-thick frozen sections were cut from the DVC at the location of A2 neurons, e.g., -14.36 to -14.86 mm posterior to bregma, and mounted on polyethylene naphthalate membrane slides (product No. 911724; Carl Zeiss Microimaging, Inc., Thornwood, NY). Tissue sections were fixed with cold acetone (product No. 179124; Sigma-Aldrich, St. Louis, MO; blocked with 5% normal horse serum (product No. PK-6120; Vectastain Elite ABC mouse IgG kit; Vector Laboratories, Burlingame, CA) diluted in 0.05 M Tris-buffered saline, pH 7.4, containing 0.05% Triton X-100 (product No. T9284; Sigma-Aldrich; TBS-Tx), and incubated for 24 hr at 4 8C with a mouse monoclonal primary antiserum against tyrosine hydroxylase (TH; product No. 22941, 1:1,000; Immunostar, Hudson, WI; RRID:AB_2313787) diluted in TBX-Tx. Sections were sequentially incubated with Vectastain IgG Elite ABC mouse IgG kit biotinylated secondary antibody, ABC reagent, and Vector DAB kit reagents (product No. SK-4100; Vector Laboratories) to visualize TH--ir neurons. Individual TH-ir cells exhibiting a visible nucleus and complete labeling of the cytoplasmic compartment were harvested with a Zeiss P.A.L.M. UV-A microlaser (Carl Zeiss Microimaging, Inc.). For each protein of interest, a minimum of three separate pools of 50 TH-ir neurons per treatment group (16-17 cells/animal) was collected into 30 ml tissue lysis buffer (2% sodium dodecyl sulfate, 0.05 M dithiothreitol, 10% glycerol, 1 mM EDTA, 60 mM Tris HCl, pH 7.2). Denatured A2 nerve cell proteins were electrophoresed in 4-20% gradient Tris-glycine gels and transblotted to 0.45-mm polyvinylidene fluoride-plus membranes (product No. PV4HY00010; Osmonics, Gloucester, MA). Membranes were pretreated with Quentix Western blot signal enhancer (Thermo Fisher Scientific, Rockford, IL), then were blocked with 0.1% Tween-20 (Sigma-Aldrich) and 2% bovine serum albumin (MP Biomedicals, Solon, OH) or 5% donkey serum prior to overnight incubation at 4 8C with primary antisera (rabbit polyclonal AMPK a1 ; goat anti-SLC5A8 (A-12), 1:500 (sc-34189; Santa Cruz Biotechnology; AB_2189838); goat anti-FAT/ CD36 (N-15), 1:500 (sc-5522; Santa Cruz Biotechnology; RRID:AB_638143); mouse anti-a-tubulin, 1:1,000 (product No. CP06; Calbiochem, Gibbstown, NJ; RRID:AB-212802) diluted in appropriate blocking solution. Membranes were subsequently incubated with peroxidase-conjugated goat antimouse (1:5,000; product No. NEF 822001EA; PerkinElmer, Boston, MA), goat anti-rabbit (1:5,000; NEF812001EA, PerkinElmer) or donkey anti-goat (1:5,000; product No. sc-2020; Santa Cruz Biotechnology; RRID:AB_631728) secondary antisera, followed by SuperSignal West Femto Maximum Sensitivity substrate (product No. 34096; Thermo Fisher Scientific). Protein band chemiluminesence imaging and densitometric analysis were performed using a Syngene G:Box Chemi image analyzer and Genetool 4.01 software. Protein optical density (O.D.) measures were normalized to a-tubulin. Protein molecular weight markers were included in each analysis. Each protein was analyzed in triplicate at minimum. Each primary antiserum detected a single-band protein as illustrated on representative blots (Table I) .
Glucose, Hormone, and FFA Analyses
Blood glucose was analyzed with an ACCU-CHECK Aviva plus glucometer (model NC; Roche Diagnostics, Indianapolis, IN; Kale et al., 2006) . Plasma glucagon (GL-32K; EMD Millipore, Billerica, MA) and corticosterone (07120102; MP Biomedicals, Santa Ana, CA) concentrations were determined by radioimmunoassay as described elsewhere (Briski and Nedungadi, 2009) . Serum ghrelin concentrations were measured by using ELISA kit reagents (EZRGRA-09K; EMD Millipore), per kit instructions. Briefly, 20-ll aliquots of serum obtained from Pefabloc-treated blood samples and assay standards were added to individual plate wells along with matrix solution, assay buffer, and antibody solution (50 ll) and incubated for 2 hr at room temperature at 400-500 rpm. After plate contents had been discarded, wells were washed three times, then incubated with enzyme conjugate (100 ll) for 30 min while shaken. Wells were emptied, washed six times, then incubated for 5-20 min with 100 ml substrate. After termination of reactions with 100 ll stop solution, content absorbance for each well was read at 450 nm in an Emax Precision Microplate Reader (Molecular Devices, Sunnyvale, CA). Circulating free fatty acid levels were analyzed by colorimetric coupled enzyme assay (MAK044; Sigma-Aldrich), per manufacturer's instructions. In brief, serum sample aliquots were added to individual plate wells and diluted to a 50-ll volume with assay buffer. Acyl-CoA synthase (2 ll) and master reaction mix (50 ll; consisting of 44 ll fatty acid assay buffer, 2 ll fatty acid probe, 2 ll enzyme mix, and 2 ll enhancer) were sequentially incubated in each well for 30 min at 37 8C in the dark. Absorbances for individual wells were read at 570 nm.
Statistical Analyses
Mean glucose, hormone, free fatty acid, and normalized A2 nerve cell protein O.D. measures were evaluated by two-way analysis of variance, with food deprivation and estradiol treatment as factors in the 2 3 2 factorial design, and Duncan's multiple range test. Differences of P < 0.05 were considered significant. Figure 1 illustrates effects of 12-hr food deprivation (FD; 2100 hr to 0900 hr) on plasma glucose (Fig. 1A) , FFA (Fig. 1B) , glucagon (Fig. 1C) , corticosterone (Fig. 1D) , and ghrelin (Fig. 1E ) concentrations in estradiol (E)-vs. oil (O)-implanted OVX female rats. Data demonstrate that each of these five parameters was statistically equivalent in full-fed E (FF/E; white diagonally striped bar) vs. O (FF/O; gray diagonally striped bar) groups. As shown in Figure 1A , FD reduced glucose levels in O but not E rats (F 3,8 5 21.69, n 5 3, P 5 0.0003, 1-b 5 1.0; FD effect: F 5 41.28, P 5 0.0002; E and FD interaction: F 5 19.98, P 5 0.002). Circulating FFA concentrations (Fig. 1B) were elevated in FD/E (solid gray bar) but not FD/O (solid white bar) groups relative to FF controls (F 3,8 5 7.01, n 5 3, P 5 0.012, 1-b 5 0.87; FD effect: F 5 16.04, P 5 0.003). FD augmented (statistically significant) and reduced (did not reach statistical significance) plasma glucagon concentrations (Fig. 1C) in O and E rats, respectively (F 3,8 5 5.004, n 5 3, P 5 0.03, 1-b 5 0.68; E and FD interaction: F 5 12.79, P 5 0.009). Corticosterone values (Fig. 1D) were significantly elevated in FD/E but not FD/O (F 3,8 5 13.03, P 5 0.008; FD effect: F 5 26.75, n 5 3, P 5 0.003, 1-b 5 0.94; E and FD interaction: F 5 9.79, P 5 0.02). Data in Figure 1E show that serum ghrelin concentrations were increased to a similar extent by FD in O and E rats (F 3,8 5 7.22, n 5 3, P 5 0.01, 1-b 5 0.86; FD effect: F 5 19.99, P 5 0.002). FD did not modify circulating insulin in E or O (Fig. 1F) , whereas serum leptin levels were reduced to an equal extent in FD/E vs. FD/O ( Fig. 1G ; F 3,8 5 19.59, n 5 3, P 5 0.0005, 1-b 5 0.92; FD effect: F 5 49.53, P 5 0.0001; E and FD interaction: F 5 6.38, P 5 0.35). Figure 2 depicts effects of FD on A2 noradrenergic neuron AMPK ( Fig. 2A) and pAMPK (Fig. 2B) protein expression. Data show that both protein profiles were significantly increased in FD/O but not FD/E (AMPK: F 3,8 5 7.53, n 5 3, P 5 0.01, 1-b 5 0.89; E effect: F 5 9.43, P 5 0.01; E and FD interaction: F 5 11.85, P 5 0.008; pAMPK: F 3,12 5 6.34, n 5 4, P 5 0.008, 1-b 5 0.89; E effect: F 5 5.93, P5.03; FD effect: F 5 10.75, P 5 0.006). Figure 2C shows that FD did not alter the mean ratio of A2 nerve cell pAMPK/AMPK protein content in O animals but did significantly enhance this protein ratio in E rats. Figure 3 illustrates the impact of FD on upstream AMPK kinase CAMKKb (Fig.  3A) and phosphatase PP2A (Fig. 3B ) profiles in A2 neurons. FD did not alter A2 CAMKKb protein content in O or E rats relative to FF controls but resulted in elevated levels of expression of this protein in FD/O vs. FD/E (F 3,8 5 3.85, n 5 3, P 5 0.05, 1-b 5 0.60; E effect: F 5 5.36, P 5 0.04; E and FD interaction: F 5 6.00, P 5 0.03). A2 PP2A protein levels were elevated in FF/E vs. FF/O and were significantly reduced by FD in E but not in O animals (F 3,12 5 7.80, n 5 4, P 5 0.003, 1-b 5 0.94; FD effect: F 5 14.34, P 5 0.002; E and FD interaction: F 5 8.38, P 5 0.01). Data in Figure 4 depict FD effects on A2 nerve cell GR and ACSVL3 proteins in E vs. O rats. FD did not alter GR levels in E or O animals 
RESULTS
DISCUSSION
Previous studies show that caudal hindbrain AMPK crucially shapes hypothalamic AMPK and metabolic neurotransmitter responses to FD in female rats and that this sensor is the primary if not exclusive source of impetus to refeed in FD/E animals . AMPKexpressing A2 noradrenergic neurons are an important Esensitive (Ibrahim et al., 2013) sensory element of the brain metabolic regulatory network (Gujar et al., 2014) . Here, pure A2 cell samples obtained by laser-catapult microdissection were analyzed by Western blot to address the hypothesis that A2 AMPK activation by FD is conditional on E, correlating with hormone effects on metabolic fuel and endocrine indicators of this metabolic imbalance. Results show that FD elevated A2 total AMPK protein but not net sensor activity in O while augmenting A2 AMPK activity without adjustment of total protein in E. Intriguingly, A2 sensor activity was refractory to glucose decrements in FD/O but augmented in FD/E rats despite unaltered glucose and elevated FFA levels. E-contingent amplification of AMPK activity may reflect adaptive reliance of A2 neurons on fatty acid oxidation and/or glucocorticoid regulation of cellular energy metabolism or sensor function. FD augmentation of A2 DbH protein profiles in FD/O but not FD/E suggests that FD may correspondingly regulate NE synthesis vs. metabolism/release in the absence vs. presence of E. Further research is needed to determine how E governs integration of diverse metabolic and endocrine (corticosterone, glucagon) cues to regulate A2 neurotransmission during FD.
E is a critical factor in systemic metabolic fuel supply in the event of FD; transient interruption of feeding over a 12-hr period resulted in differential changes in blood glucose and FFA levels in E-vs. O-implanted OVX female rats. Results show that, as with gonad-intact male rats (Le Magnon et al., 1980) , FD/O animals displayed reductions in circulating glucose, but contrary to that earlier work FFA levels were not coincidently elevated. In contrast, FD/E animals exhibited no glucose decrements alongside augmented FFA, implying that enhanced substrate fuel availability is a mechanism of E defense against cell energy deficiency. A2 nerve cell ACSVL3 protein content was greater in FF/E vs. FF/O (despite equivalent plasma FFA levels) groups and in FD/E vs. FD/O animals, data suggesting that E may increase FFA utilization by these cells during energy sufficiency as well as shortterm suspension of fuel acquisition. FD elevated plasma glucagon (statistically significant) or reduced (did not reach statistical significance) concentrations in O and E rats, respectively, to the extent that hormone levels diverged significantly in FD/O vs. FD/E. The FDassociated decline in FD/E glucagon may be causally related, in part, to FFA augmentation, in that FFA reportedly inhibits glucagon secretion (Gerich et al., 1974; Luyckx et al., 1978) . Plasma corticosterone levels were significantly elevated in response to FD in E, resulting in disparate output in FD/E vs. FD/O. At the same time, A2 neuron GR protein levels were significantly higher in FD/E vs. FD/O. These data imply that E enhances glucocorticoid regulation of A2 function during FD through mechanisms involving amplification of both strength of hormone signal and cell sensitivity to this stimulus. Because FFA increases corticosterone output via putative central actions (Widmaier et al., 1995) , FFA may mediate E-dependent amplification of circulating corticosterone. FD elevated plasma ghrelin levels to an equivalent extent in E and O rats. Ghrelin receptor-ir is localized to the DVC but is absent from resident catecholamine neurons (Bron et al., 2013) , so we did not analyze ghrelin receptor protein in A2 neurons. However, we cannot discount the possibility that E may regulate ghrelin receptor expression in local or distant sources of afferent input to these cells under normoenergetic or energy-deficit condition.
The current data point to E regulation of A2 nerve cell AMPK reactivity to FD because total AMPK protein content was increased without adjustment of activity in FD/O, whereas net AMPK levels were stabilized alongside augmented phosphorylation in FD/E. In previous work, we found that FD did not affect cDVC AMPK levels in O rats . This deviation of A2 cells from the averaged cDVC response suggests that FDassociated intensification of A2 total AMPK protein is evidently masked by dissimilar changes in this protein profile in non-A2 cells. Unlike total AMPK, pAMPK profiles were elevated in both cDVC tissue and A2 neurons in FD/O animals. In FD/E rats, A2 neurons are excluded from the trend of FD-associated reduction in cDVC pAMPK levels. These results support the unique concept that A2 neurons respond differently to FD vs. non-A2 AMPK-expressing cells in the female rat cDVC, regardless of the presence or absence of E. Data also show that the pAMPK/AMPK ratio was increased in A2 neurons from FD/E but not FD/O rats. On one hand, FD may result in net ATP deficiency or AMP excess in A2 cells in the presence of E, a premise that remains speculative bacause analytical methods of requisite sensitivity for measurement of AMP/ATP levels in A2 cells in vivo are not currently available. Alternatively, A2 AMPK activity may be augmented in FD/E independently of ATP status, through mechanisms involving receptor-mediated actions of endocrine/neurotransmitter signals such as FFA and corticosterone. Indeed, FFA is reported to exert allosteric effects that promote AMPK phosphorylation independently of energy state (Watt et al., 2006) , whereas corticosterone is likewise observed to regulate hypothalamic AMPK activity directly (Shimizu et al., 2008) . The latter possibility of a non-AMP/ATP ratio-based mechanism for FD regulation of A2 AMPK activity in the presence of E is supported by current evidence for downregulation of the AMPK upstream protein phosphatase PP2A in FD/E, an outcome that would likely attenuate AMPK deactivation via dephosphorylation. It is noted that present measures of upstream kinase and phosphatase protein expression do not address the possibility that food deprivation may influence enzyme activity via phosphorylation or methylation. Further research is required to determine whether E-dependent adjustments in net AMPK activity in response to FD are achieved by direct hormone action on A2 neurons or through E-driven chemical inputs to these cells.
E regulates effects of FD on A2 nerve cell expression of the catecholamine biosynthetic enzyme DbH because this protein profile was increased in FD/O but not FD/E. Current evidence for parallel upregulation of DbH and total/phosphorylated AMPK suggests that expression of these proteins may be governed in tandem. In FD/E, A2 DbH content was unchanged despite increased AMPK activation. Previous studies show that cDVC hindbrain AMPK is a critical determinant of hyperphagic and hypothalamic AMPK responses in FD/E rats insofar as pharmacological inhibition of this sensor normalizes those functions. If the premise that increased DbH expression is an accurate indicator of elevated norepinephrine synthesis and release is correct, our data would imply that A2 cells do not convey cDVC AMPK-initiated signals to the brain metabolic regulatory circuitry. Norepinephrine is coexpressed with other neurotransmitters, including neuropeptide Y, neurotensin, and dynorphin, so an alternative possibility is that A2 neurons communicate FD effects via nonnoradrenergic stimuli. On the other hand, we cannot disregard the prospect that, notwithstanding a lack of change in DbH protein expression, FD may regulate A2 norepinephrine transmission through control of norepinephrine metabolism and release within projection sites. Indeed, FD elicits adjustments in tissue norepinephrine content in different forebrain structures in O vs. E animals, responses that are attenuated by the AMPK inhibitor Cc . We speculate that E may determine downstream targets of norepinephrine noradrenergic signals of hindbrain sensor status through actions at noradrenergic axon terminals to "silence" or "unsilence" AMPK-sensitive norepinephrine release within distinct forebrain loci.
In summary, the current research shows that FD reduces and does not impact circulating glucose in O and E animals, respectively, while elevating FFA in E rats only (Fig. 6 ). A2 nerve cell AMPK activity was refractory to FD/O but augmented in FD/E. E-contingent amplification of AMPK activity may reflect adaptive conversion of energy metabolism from carbohydrate to fatty acid oxidation and/or glucocorticoid stimulation. FD augmentation of A2 DbH protein profiles in FD/O but not FD/E implies that FD may correspondingly regulate norepinephrine synthesis vs. metabolism/release in the absence vs. presence of E. Further studies are needed to clarify how metabolic and hormonal surrogates of FD are translated by A2 neurons into regulatory inputs to the brainwide circuitry that defends energy balance.
